The genome is the blueprint, but the epigenome tells it how to be read. Chemical modifications like DNA methylation and histone changes act as switches that influence health, development, and disease.

Admera Health provides advanced epigenomic sequencing services—from WGBS and EM-seq to Targeted Methyl-seq, ChIP-seq, and CUT&RUN—delivering reliable results even from challenging samples. Partner with us to unlock the next layer of genetic discovery.

Thinking about starting a spatial transcriptomics project?
Explore key considerations for choosing the right platform, preparing your samples, and planning your analysis to generate high-quality, spatially resolved gene expression data.

Admera Health partners with top Certified Service Providers to deliver cutting-edge genomics with precision, reliability, and innovation—empowering breakthroughs that move science forward.

Drug discovery is long, costly, and often slowed by sample loss that compromises NGS data. Admera Health provides expert support and advanced lab services to help biopharma accelerate discoveries with reliable, high-quality results.

Significant nucleic acid sample loss during extraction often bottlenecks Next-Generation Sequencing (NGS), compromising data quality and delaying discoveries. Admera Health intimately understands this challenge, which is why we're thrilled to partner with BioEcho, innovators of the revolutionary EchoLUTION™ nucleic acid purification technology. This strategic alliance ensures clients achieve higher yields and more robust NGS results right from the first step of their research.

Proteomics is revolutionizing biological discovery by providing real-time insights into protein function, disease mechanisms, and biomarker identification. Explore how proteomics enhances multi-omics research by revealing functional protein insights for biomarker discovery, drug target validation, and disease research.

Metabolomics provides a dynamic snapshot of cellular activity, capturing how metabolites reveal the intricate dance of metabolism and environment. Paired with genomics and transcriptomics, this comprehensive approach unlocks unparalleled insights into disease mechanisms, biomarkers, drug response, and microbiome-host interactions. Admera Health bridges the gap between these layers, offering robust NGS services to enhance multi-omics integration, paving the way for impactful discoveries.

Transform your research with single-cell sequencing. Discover rare cells & complex biology at high resolution. Learn how single-cell sequencing can support diverse research applications from immunology to cancer research

Dr. David Christiani was recently awarded 1st prize for Admera Health’s single-cell sequencing grant contest. We were delighted to sit down with David and learn more about his research on the human genome and the environment with recent interest in personalized medicine to better understand why patients vary in both curative and palliative therapies.

Working with FFPE samples can be challenging, but it doesn't have to be! In our recent blog post, we discuss what FFPE is, its effect on samples, and how we can obtain meaningful insights from these important samples.

NGS is an instrumental tool advancing research related to human health, infectious disease, cancer, and much more. In addition to improving research of the human genome, NGS is a powerful tool for advancing plan and animal studies. Learn how our clients used NGS to propel their studies relating to plant and animal conservation, evolutionary research, infectious disease, and population genetics.

Admera Health provides a high-quality spatial transcriptomics workflow using Stereo-seq, for in-depth understanding of the relationship among gene expression, cell morphology, and cellular microenvironments. Stereo-seq combines DNA nanoball (DNB)-patterned arrays and ISS to explore spatial biology at nanometer resolution. Read more about spatial transcriptomics and stereo-seq in our blog post.

Learn about Admera Health’s whole genome sequencing workflow step-by-step.

In the ever-evolving field of genomics, single-cell RNA sequencing (scRNA-seq) has emerged as a groundbreaking technology that allows researchers to delve into the intricate world of gene expression at the single-cell level. Admera Health takes diffcult single-cell RNA sequencing data and extract meaningful insights from the data.